Frankfurt - Delayed Quote EUR

Croda International Plc (6CMB.F)

Compare
37.93
-0.53
(-1.38%)
As of 8:02:00 AM GMT+1. Market Open.
Loading Chart for 6CMB.F
DELL
  • Previous Close 38.46
  • Open 37.93
  • Bid 37.40 x --
  • Ask 38.19 x --
  • Day's Range 37.93 - 37.93
  • 52 Week Range 37.11 - 59.50
  • Volume 90
  • Avg. Volume 7
  • Market Cap (intraday) 5.326B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 27.09
  • EPS (TTM) 1.40
  • Earnings Date Feb 25, 2025
  • Forward Dividend & Yield 1.29 (3.35%)
  • Ex-Dividend Date Sep 5, 2024
  • 1y Target Est --

Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations. In addition, the company offers crop protection and seed enhancement related solutions. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.

www.croda.com

5,852

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6CMB.F

View More

Performance Overview: 6CMB.F

Trailing total returns as of 2/6/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

6CMB.F
6.99%
FTSE 100
6.65%

1-Year Return

6CMB.F
33.20%
FTSE 100
13.48%

3-Year Return

6CMB.F
56.95%
FTSE 100
15.97%

5-Year Return

6CMB.F
31.52%
FTSE 100
16.15%

Compare To: 6CMB.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6CMB.F

View More

Valuation Measures

As of 2/5/2025
  • Market Cap

    5.22B

  • Enterprise Value

    5.83B

  • Trailing P/E

    27.44

  • Forward P/E

    17.18

  • PEG Ratio (5yr expected)

    1.11

  • Price/Sales (ttm)

    2.74

  • Price/Book (mrq)

    1.92

  • Enterprise Value/Revenue

    2.98

  • Enterprise Value/EBITDA

    12.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.98%

  • Return on Assets (ttm)

    3.69%

  • Return on Equity (ttm)

    7.03%

  • Revenue (ttm)

    1.63B

  • Net Income Avi to Common (ttm)

    162.7M

  • Diluted EPS (ttm)

    1.40

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    209.3M

  • Total Debt/Equity (mrq)

    30.70%

  • Levered Free Cash Flow (ttm)

    93.61M

Research Analysis: 6CMB.F

View More

People Also Watch